Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56

NCT01235351 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

335

Enrollment

OTHER

Sponsor class

Conditions

Myocardial Infarction
Percutaneous Coronary Intervention

Interventions

DRUG: Clopidogrel
DRUG: Clopidogrel

Sponsor

The TIMI Study Group

Collaborators

[object Object]
[object Object]